Results

Total Results: 1,640 records

Showing results for "therapy".

1281. Slide 1 (ppt file)
      effectivehealthcare.ahrq.gov/sites/default/files/module_ii1.ppt
      June 01, 2011 - For Original Research, stakeholders might advise on the treatment options to evaluate, study populations … For example, patients & consumers may be most interested in treatment options, benefits and harms, and … Clinicians may be most interested in clinical outcomes, and diagnostic and treatment options for their … Frontline clinicians working directly with patients offer unique insights into the context of diagnosis and treatment … Exercise 7: Identifying & Recruiting Stakeholders Imagine you are involved in research comparing multiple therapies

1282. AHRQ Evidence-based Practice Center Program Research Gaps Summary: Telehealth (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/ehc-research-gaps-telehealth.pdf
      April 01, 2023 - less desirable for patients with complex clinical conditions, those needing physical exams, and for therapies … screening, counseling, provision, followup care) or receiving services for screening, evaluation, or treatment

1283. Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment: Comparative Effectiveness Update | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/cancer-anemia-update/research

1284. Vulvar Cancer | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/health-topics/vulvar-cancer

1285. Throat Cancer | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/health-topics/throat-cancer

1286. Child Behavior Disorders | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/health-topics/child-behavior-disorders

1287. Cancer-Ovarian-Contraceptives Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_executive.pdf
      June 01, 2013 - highest incidence (60 years and older).2 While advances in surgery, chemotherapy, and radiation therapy … research agenda and clinical recommendations, as evidenced by the experience with hormone replacement therapy … in preventing unintended pregnancies; the potential effectiveness of OCs as primary or adjunctive treatments … with the target population, version or characteristics of the intervention used in comparison with therapies … be reassuring to women considering OCs for contraception and to women who are prescribed OCs for treatment

1288. Comparative Effectiveness of Strategies to De-escalate Aggressive Behavior in Psychiatric Patients in Acute Care Settings (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/aggression_executive.pdf
      October 01, 2016 - These include improved quality of life, functioning, or patient experience; improved therapeutic relationship … patient psychological trauma, decreased adherence Final Outcomes • QOL • Patient experience • Therapeutic … Systematic reviews of assessment measures and pharmacologic treatments for agitation. … Effects of a recovery- oriented cognitive therapy training program on inpatient staff attitudes and … Effectiveness of cognitive- behavioural group therapy for inpatients.

1289. Erythropoiesis-Stimulating-Agents-Utilization Research (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/erythropoiesis-stimulating-agents-utilization_research.pdf
      February 01, 2011 - beginning in the late 1990s,6 suggested potential adverse cardiovascular out- comes arising from ESA therapy … decline upon publication of relevant studies (e.g., Cardiovascular Risk Reduction by Early Anemia Treatment … Anemia in chronic kidney disease: causes, diagnosis, treatment. … The HCPCS codes used for identifying ESA treatment are available from the authors.

1290. Conducting Quantitative Synthesis when Comparing Medical Interventions: AHRQ and the Effective Health Care Program (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-quantitative-synthesis_methods.pdf
      October 01, 2010 - this article is to summarize our recommendations in conducting quantitative synthesis of CERs for therapeutic … population less comparable over time, while the effectiveness of the initial highly-active antiretroviral therapy … Two treatments are suggested to have comparable effectiveness if their direct effects vs. a common … Simultaneous comparison of multiple treatments: combining direct and indirect evidence. … Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside

1291. Conducting Quantitative Synthesis when Comparing Medical Interventions: AHRQ and the Effective Health Care Program (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_conductingquantitativesynthesis.pdf
      October 01, 2010 - this article is to summarize our recommendations in conducting quantitative synthesis of CERs for therapeutic … population less comparable over time, while the effectiveness of the initial highly-active antiretroviral therapy … Two treatments are suggested to have comparable effectiveness if their direct effects vs. a common … Simultaneous comparison of multiple treatments: combining direct and indirect evidence. … Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside

1292. The Refinement of Topics for Systematic Reviews: Lessons and Recommendations From the Effective Health Care Program (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-topic-refinement_methods.pdf
      January 01, 2013 - a particular technology; share their opinions about the advantages or disadvantages about specific treatments … , therapy, or intervention (depicted with solid line) (KQ X) (KQ X) (KQ X) (KQ X) … (or if no current treatments are available, what is your understanding of the natural progression of … In general, the figure illustrates how [treatment 1] versus [treatment 2] may result in intermediate … PICO (Outcome): Outcomes include looking at potential harms and benefits of various treatments

1293. Melanoma | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/health-topics/melanoma

1294. Mrsa-Screening-2010 Research-Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/mrsa-screening-2010_research-protocol.pdf
      January 01, 2010 - facilities where vulnerable hosts, frequent exposure to the selective pressure of intensive antimicrobial therapy … the community who lack conventional risk factors for MRSA infection (such as prior antimicrobial therapy … O Were participants in treatment groups recruited within the same time period? … O Were concurrent/concomitant treatments clearly specified and given equally to treatment groups? … Future treatment options for Gram-positive infections—looking ahead.

1295. Cad-Women-Diagnosis Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_executive.pdf
      June 01, 2012 - object is to help consumers, health care providers, and others in making informed choices among treatment … Effectiveness Reviews, the program supports systematic appraisals of existing scientific evidence regarding treatments … Decisionmaking regarding treatment options (e.g., revascularization, optimal medical therapy)? … —none, medical therapy, percutaneous coronary intervention, or coronary artery bypass surgery • … further NIT testing or coronary angiography; and the clinical outcomes may be influenced by the medical treatments

1296. Module II: Stakeholders and Stakeholder Engagement (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/module-ii-stakeholders-and-stakeholder-engagement.pdf
      June 01, 2011 - For Original Research, stakeholders might advise on the treatment options to evaluate, study populations … For example, patients & consumers may be most interested in treatment options, benefits and harms, and … Clinicians may be most interested in clinical outcomes, and diagnostic and treatment options for their … clinicians working directly with patients offer unique insights into the context of diagnosis and treatment … Exercise 7: Identifying & Recruiting Stakeholders Imagine you are involved in research comparing multiple therapies

1297. Suppl-2-User-Guide-To-Ocer 130129 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/suppl-2-user-guide-to-ocer_130129.pdf
      January 01, 2011 - primary goal of nonexperimental comparative effectiveness research is to compare the effect of study treatments … studies, marginal exchangeability can rarely be assumed, since patients and providers typically select treatments … To simplify, consider a randomized trial of antihypertensive treatments (CCB or other) and the outcome … alcohol abuser but remained in the study suggests that she did not experience adverse effects of therapy … Treatment (A) is randomized.

1298. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update--Executive Summary (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/antipsychotics-children-update_executive.pdf
      January 01, 2018 - as well as behavioral issues, for which antipsychotics are being prescribed as mono- or adjunctive therapy … antipsychotic or cotreatments including other antipsychotics, other medications, or nonpharmacologic therapy … per clinical characteristics: presence of cotreatments (e.g., other medication, nonpharmacological therapy … • Studies incorporating therapeutic drug monitoring over long-term periods in naturalistic settings … Studies incorporating therapeutic drug monitoring over long-term periods in naturalistic settings could

1299. Since their introduction in 20xx, DES have been shown in clinical trials to decrease TLR (… (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-stents-outcomes_research.pdf
      January 01, 2010 - Additionally, we plotted the treatment-group specific cumulative incidence rates excluding events from … the first 6 and 12 months to identify the long-term component of the treatment effect. … Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. … Utilizing propensity scores to estimate causal treatment effects with censored time- lagged data. … Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention: A

1300. Stroke Prevention in Atrial Fibrillation | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/stroke-atrial-fibrillation/research